At any given moment this week, it is estimated that as much as a quarter of the world’s population is in a state of lockdown, countless others are required on the frontline of fighting the spread of Covid-19, and hundreds of thousands of people are confirmed to be infected with the virus – many of which are hospitalised or requiring treatment.
Oxygen is on the frontline too, and in hot demand. Medical oxygen is being used in its most critical form in treating coronavirus patients, in the areas of respiration, incident response and life support. Right now it’s about that getting that oxygen into patients and keeping their vital functions active.
With such a spotlight on medical oxygen and questions over supply chain stability to meet current and anticipated demand, does this bring greater attention to a less utilised means of oxygen supply, onsite generation via pressure swing adsorption (PSA)?
... to continue reading you must be subscribed
